esquizofrenia

Neuroimmune biomarkers in schizophrenia

Schizophrenia Research 176 (2016) 3–13

Implications for reactive oxygen species in schizophrenia pathogenesis

Schizophrenia Research 176 (2016) 52–71

Clinical studies of neuroinflammatory mechanisms in schizophrenia

Schizophrenia Research 176 (2016) 14–22

Reviewing the ketamine model for schizophrenia

Journal of Psychopharmacology 2014, Vol. 28(4) 287– 302

L-theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8Week,
Randomized, Double Blind, Placebo Controlled, 2-center Study

J Clin Psychiatry 2011;72(1):34–42

L-theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8Week,
Randomized, Double Blind, Placebo Controlled, 2-center Study

J Clin Psychiatry 2011;72(1):34–42

L-theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8Week,
Randomized, Double Blind, Placebo Controlled, 2-center Study

J Clin Psychiatry 2011;72(1):34–42

Effect of L-theanine on glutamatergic function in patients with schizophrenia

250 mg/day Acta Neuropsychiatrica 2015

L-theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8Week,
Randomized, Double Blind, Placebo Controlled, 2-center Study

J Clin Psychiatry 2011;72(1):34–42

Efficacy and safety of extract of Ginkgo biloba as anadjunct therapy in chronic schizophrenia: A systematic review of randomized,
double-blind, placebo-controlled studies with meta-analysis

Psychiatry Research 228(2015)121–127

Efficacy and safety of extract of Ginkgo biloba as anadjunct therapy in chronic schizophrenia: A systematic review of randomized,
double-blind, placebo-controlled studies with meta-analysis

Psychiatry Research 228(2015)121–127

Efficacy and safety of extract of Ginkgo biloba as anadjunct therapy in chronic schizophrenia: A systematic review of randomized,
double-blind, placebo-controlled studies with meta-analysis

Psychiatry Research 228(2015)121–127

Effects of a standardized extract of Withania somnifera (Ashwagandha) on depression and anxiety symptoms in persons with schizophrenia
participating in a randomized, placebo-controlled clinical trial

1.000 mg ANNALS OF CLINICAL PSYCHIATRY 2019;31(2):123-129

Effects of a standardized extract of Withania somnifera (Ashwagandha) on depression and anxiety symptoms in persons with schizophrenia
participating in a randomized, placebo-controlled clinical trial

1.000 mg ANNALS OF CLINICAL PSYCHIATRY 2019;31(2):123-129

Desordem bipolar
Bipolar disorder: An evolutionary psychoneuroimmunological approach

Neuroscience and Biobehavioral Reviews 122 (2021) 28–37

Bipolar disorders

NATURE REVIEWS | DISEASE PRIMERS

Bipolar disorders

NATURE REVIEWS | DISEASE PRIMERS

Bipolar disorders

NATURE REVIEWS | DISEASE PRIMERS

Bipolar disorder and the endocannabinoid system

Neuropsychiatrica 31:193–201.
Revisiting inflammation in bipolar disorder

Pharmacology, Biochemistry and Behavior 177 (2019) 12–19

Bipolar disorder

Lancet 2016; 387: 1561–72

Bipolar disorder

Lancet 2016; 387: 1561–72

Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-
analysis

La Revue Canadienne de Psychiatrie 1-15

OBRIGADO